文献速递免疫规划妇幼与学校卫生

贝宁婴儿接种4剂乙肝疫苗(含出生时接种)与标准3剂方案抗-HBs抗体应答比较:一项横断面调查

Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey.
PubMed 文献 · Vaccine · 2019-12-19

2017年4月至9月在贝宁南部两个疫苗单位开展横断面调查,比较婴儿接种3剂(6、10、14周)与4剂(含出生时0周)乙肝疫苗后的抗-HBs应答。4剂组抗-HBs水平显著高于3剂组(557.9 UI/L vs 386.9 UI/L,P=0.03),持续保护应答也更高(aOR 2.49,95%CI 1.03-6.03,P=0.04)。

要点

  • 4剂乙肝疫苗(含出生时接种)组抗-HBs水平显著高于3剂组(557.9 UI/L vs 386.9 UI/L,P=0.03)。
  • 4剂方案持续保护应答显著高于3剂方案(aOR 2.49,95%CI 1.03-6.03,P=0.04)。
  • 婴儿和母亲HBV感染率分别为2.2%和7.1%。

核心结论

  • 4剂乙肝疫苗(含出生时接种)方案较3剂方案诱导更高的抗-HBs水平和持续保护应答,为出生时接种乙肝疫苗提供进一步证据,并凸显预防垂直传播的重要性。
  • 在将出生时乙肝疫苗接种纳入扩大免疫规划前,需进一步研究以更好确定该4剂免疫策略的成本效益。

研究设计与样本

  • 2017年4月至9月在贝宁南部两个疫苗单位开展横断面调查。
  • 系统收集前140名9月龄婴儿及其同意参与的母亲的血样,检测HBs抗原并定量抗-HBs抗体。
  • 比较标准3剂方案(6、10、14周)与4剂方案(0、6、10、14周,含出生时接种)诱导的抗-HBs应答。

主要发现

  • 婴儿HBV感染率为2.2%,母亲HBV感染率为7.1%。
  • 接种4剂乙肝疫苗的婴儿抗-HBs抗体水平显著高于接种3剂者(557.9 UI/L vs 386.9 UI/L,P=0.03)。
  • 4剂方案与3剂方案相比,持续保护应答显著更高(aOR 2.49,95%CI 1.03-6.03,P=0.04)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文指出需进一步研究以更好确定该4剂免疫策略的成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis B virus (HBV) infection remains one of the major neglected health issues worldwide. In sub-Saharan Africa (SSA), HBV endemicity is high, with more than 8% of the population being chronic HBV carriers. Recently, WHO recommended that all infants should receive their first dose of the HBV vaccine as soon as possible after birth. Unfortunately, the incorporation of a birth dose of HBV in the expanded programme immunization (EPI) has not occurred in the majority of countries in SSA. From April to September 2017, a cross-sectional survey was conducted in two vaccine units located in southern Benin. We assessed the sustained anti-HBs antibody response in infants induced by a standard scheme of 3 doses of HBV vaccination (6, 10, 14 weeks) in comparison to a scheme of 4 doses with a birth dose included (0, 6, 10, 14 weeks). Blood samples were systematically collected in the first 140 children aged 9 months and their mothers who had consented to participate for the detection of HBs antigen and the quantification of anti-HBs antibodies. The prevalence of HBV infection among infants and mothers was 2.2% and 7.1%, respectively. Infants who received 4 doses of HBV vaccine had a significantly higher level of anti-HBs antibody than those who received 3 doses of vaccine (557.9 UI/L vs. 386.9 UI/L, respectively, P = 0.03). We also showed that the scheme of 4 doses was associated with a significantly higher sustained protective response in comparison to the scheme of 3 doses (aOR 2.49, 95% CI 1.03-6.03, P = 0.04). This result provides further evidence of the importance of administering HBV vaccine at birth, but also highlights the importance for the prevention of vertical transmissions. Additional studies are needed to better establish the cost-effectiveness of such a 4 doses immunization strategy before implementing the HBV vaccination at birth in the EPI.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Accrombessi M, Adetola CV, Bacharou S, et al. Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey. Vaccine. 2019. PMID: 31866185. doi:10.1016/j.vaccine.2019.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。